Abstract
Brain activity fluctuates continuously, even in the absence of changes in sensory input or motor output. These intrinsic activity fluctuations are correlated across brain regions and are spatially organized in macroscale networks. Variations in the strength, topography, and topology of correlated activity occur over time, and unfold upon a backbone of long-range anatomical connections. Subcortical neuromodulatory systems send widespread ascending projections to the cortex, and are thus ideally situated to shape the temporal and spatial structure of intrinsic correlations. These systems are also the targets of the pharmacological treatment of major neurological and psychiatric disorders, such as Parkinson's disease, depression, and schizophrenia. Here, we review recent work that has investigated how neuromodulatory systems shape correlations of intrinsic fluctuations of large-scale cortical activity. We discuss studies in the human, monkey, and rodent brain, with a focus on non-invasive recordings of human brain activity. We provide a structured but selective overview of this work and distil a number of emerging principles. Future efforts to chart the effect of specific neuromodulators and, in particular, specific receptors, on intrinsic correlations may help identify shared or antagonistic principles between different neuromodulatory systems. Such principles can inform models of healthy brain function and may provide an important reference for understanding altered cortical dynamics that are evident in neurological and psychiatric disorders, potentially paving the way for mechanistically inspired biomarkers and individualized treatments of these disorders.
Introduction: The "Knobs and Levers" of Brain Activity
Even in a state of rest, the human brain is a hive of activity. These spontaneous fluctuations are not random; they are highly correlated across distant regions, forming what are known as "resting-state networks." While these networks are constrained by the brain's physical anatomical connectome, anatomy alone cannot explain why these patterns shift during different states of arousal, attention, or disease.
This review synthesizes evidence that subcortical neuromodulatory systems—tiny brainstem nuclei—act as the primary "conductors" of this variability. By releasing neuromodulators like norepinephrine, dopamine, and serotonin, these systems dynamically reshape the brain's intrinsic activity patterns, providing a mechanistic bridge between neurochemistry and macroscale brain function.
Mapping the Neuromodulatory Landscape
The brainstem houses several key nuclei that send widespread ascending projections to the cortex. These include the noradrenergic locus coeruleus, the dopaminergic substantia nigra and ventral tegmental area, the serotonergic raphe nuclei, and the cholinergic basal forebrain.
Researchers utilize a variety of modalities to study these systems, ranging from fMRI and MEG/EEG in humans to optogenetics in animal models. A critical resource in this field is the mapping of receptor gene expression across the cortex. High-resolution datasets (such as Gryglewski et al., 2018) provide templates of where specific receptors (e.g., $\alpha_{2A}$, $D_1$, or $5HT_{2A}$) are located, allowing researchers to correlate pharmacological effects with specific molecular targets.
Mechanisms of Modulation: Activity vs. Dynamic States
The review distinguishes between two primary modes of subcortical influence:
- Activity State (Fast): The brainstem sends a "common drive" to multiple cortical areas simultaneously, causing them to fluctuate in unison via fast-acting ionotropic receptors.
- Dynamic State (Slow): Neuromodulators change the "local rules" of cortical circuits (e.g., changing the excitation-inhibition balance) via slower metabotropic receptors. This alters "neural gain," effectively tuning how loudly different brain regions communicate with one another.
Key Findings Across Systems
- Norepinephrine (NE): Boosting NE (e.g., via atomoxetine) consistently shows a reduction in global correlation strength during rest and a shift in network integration.
- Acetylcholine (ACh): Essential for network integrity; inactivating the basal forebrain in macaques leads to a massive drop in global fMRI correlations.
- Serotonin (5HT): Agonists like LSD increase global connectivity and reduce the "modularity" of the brain, blurring the usual boundaries between functional networks.
- Dopamine (DA): DA depletion, as observed in Parkinson’s disease, reduces the stability and integration of intrinsic networks, particularly those involving the sensorimotor cortex.
Future Directions and Clinical Translation
Several hurdles remain, including the "Global Signal" problem in fMRI—where standard preprocessing may inadvertently remove the very neuromodulatory effects researchers seek to study. Furthermore, most studies look at one neurotransmitter at a time, whereas the brain naturally operates on a "cocktail" of simultaneous modulators.
The ultimate goal is to use these correlation patterns as "mechanistically inspired biomarkers." By comparing a patient's connectivity map to reference templates of specific neuromodulator effects, clinicians may one day be able to tailor pharmacological treatments to an individual's specific neurochemical deficit, paving the way for personalized medicine in psychiatry and neurology.
Summary updated